Document is current
Any future updates will be listed below
-
Authors
Wang, Long
Wu, Guofeng
Cao, Ai
Huang, Lei
Wang, Haoqi
Ren, Siying
Gao, Bo
Wang, Likun https://orcid.org/0000-0003-0517-4723
-
Funding
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (82260244)
The Leading Discipline Program of The Affiliated Hospital of Guizhou Medical Uni-versity (gyfyxkrc-2023–05)
Key lab of acute brain injury and function repair in Guizhou Medical University ([2024] fy0071)
the key Advantageous Discipline Construc-tion Project of Guizhou Provincial Health Commission in 2023
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 10 July 2025
First Online: 5 August 2025
Declarations
:
: The authors have no conflicts of interest to declare.
: This research received approval from the Ethics Committee of the Affiliated Hospital of Guizhou Medical University (ethics review approval no. 92, 2022, and approval no. 2024031K). Prior to participation, informed consent was obtained from all patients or their legal representatives. The study was conducted in strict accordance with the ethical standards outlined in the World Medical Association Declaration of Helsinki, ensuring the protection of human participants in medical research.
: “Effect of Apolipoprotein E on the Prognosis of Patients with Intracerebral Hemorrhage” was registered on ClinicalTrials.gov (prospective registration NCT05687201; date: Jan 18, 2023; ).
